"The AIQ software will greatly improve the interpretation of PET/CT and PET/MRI scans in patients who have had multiple exams. The analysis of these exams will be more thorough and comprehensive and should save the interpreting nuclear medicine physician or radiologist a lot of time.
The ability to determine which lesions have responded to therapy and which are resistant in patients with a large metastatic disease burden will allow great improvements in patient care and hopefully lead to improved survival in oncology patients. Software like this will surely be an important part of image interpretation in the future."
Dr. Scott Perlman M.D., M.S.
Associate Section Chief, UW Nuclear Medicine & Molecular Imaging University of Wisconsin School of Medicine and Public Health Consultant to AIQ
RALEIGH, N.C., June 9, 2022 /PRNewswire/ -- Lucem Health™ today launched the Lucem Health Innovation Collaborative, a partner program designed to move clinical AI/ML innovation to the front lines of healthcare. The Collaborative will help digital health innovators create, deploy, and commercialize transformational solutions powered by artificial intelligence and machine learning models.